Virginia Governor Abigail Spanberger has signed two bills that will automatically legalize a medical formulation of psilocybin once it receives federal approval. The measures, HB 1347 and SB 379, direct the state Board of Pharmacy to reschedule any FDA‑approved psilocybin product at its first quarterly meeting after federal scheduling changes are published. The legislation is narrowly tailored to formulations administered by health care professionals in clinical settings, positioning Virginia to move quickly if federal regulators give the green light.
At the national level, Health and Human Services Secretary Robert F. Kennedy Jr. has signaled the Trump administration is eager to open access to psychedelic therapies for conditions such as PTSD and depression in tightly controlled environments. Read the full original report at Marijuana Moment.